Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

Clinical trial NCT06561399 · RECRUITING

Trial details

NCT number: NCT06561399
Sponsor: Fujian Provincial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2024-08-15
Primary completion: 2027-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.